Dive deeper

Got a moment? Technology governance can be complex. Our series explore some of the more expansive questions underpinning technology governance in greater detail.

AI Governance Challenges

AI is a fairly novel technology – and it presents policymakers with some particularly tricky questions. This series explores some of these challenges in in detail.

Biotechnology and the next pandemic

This series examines how biotechnology misuse could contribute to future pandemics, exploring emerging risks, biosecurity challenges, and Europe’s preparedness against evolving threats.

Emerging biotech atlas

A living guide for policymakers aiming to cut through jargon and hype to support informed, balanced engagement with fast-evolving biotechnologies.

Neurotech between wellness and medicine

The rapid growth of wellness neurotechnologies is revealing a regulatory grey zone between medical and consumer markets. These devices operate at the intersection of strong commercial incentives, pressing public health needs, and regulatory frameworks designed for a time when the boundary between medical and consumer products was far clearer. In this series of articles, CFG examines that tension from multiple perspectives, concluding with a proposal for how regulators can respond to support ethical innovation.

Policymakers’ questions explored

As part of our ongoing work, we are actively engaging with policymakers and other stakeholders, and learning alongside them about emerging climate intervention issues, their broader implications, and governance needs. In this series, we explore those questions on a deeper leve. Read our Policymakers’ FAQ for an overview.